Hereditary Pan-Cancer Test
 

There are more than 200 different types of hereditary cancer syndrome. CloudHealth provides different combinations of genetic tests for different types of hereditary cancer syndrome with a total of 55 genes. Certain genetic test can be selected according to personal and family history.

 
Tumor type
Breast cancer, ovarian cancer, Gastric cancer and so on
 
Sample type
peripheral blood; oral mucosa cells; saliva.
 
Turnaround time
30 days
Why get tested?

Individuals suspected of having cancer risk, he/she will have the time to work with healthcare provider or physicians to make choices that feel right for him/her:

  • Initialing screening considerably earlier

    For individuals who have elevated colon cancer risk, colonoscopies should be performed earlier and more frequently.

  • Chemoprevention

    Some common medications have been shown to reduce the risk of cancers. For example, aspirin can reduce the risk of hereditary colon cancer.

  • Risk reduction surgery

    Prevention usually involves surgical removal of the at-risk tissue, for example, conducting bilateral risk-reduction mastectomy (RRM) deceased risk of developing breast cancer in known BRCA1/2 mutation carriers.

Meaning

Cancer is a genetic disease caused by changes to genes. Approximately 5–10% of cancers are due to inherited genetic defects of cancer predisposition genes from a person's parents. Genetic tests can help estimate risks of developing cancer in one’s lifetime. Variants can be classified into pathogenic variants, benign variants, variants of uncertain significance and so on. Pathogenic variants may increase lifetime risks of cancer.

Test panel

 

 


       

Process
  • Sample collection

    EDTA anticoagulative tube for 3-5 mL peripheral blood; mouth swabs for oral mucosa cells; saliva collection for saliva.

  • Test and analysis

    Turnaround time from sample receipt to report issue is 25 days.

  • Issuing Reports

    Issuing report and providing genetic counseling.




Advantages
  • Advanced technology

    The target region covers all coding exons of BRCA1 and BRCA2 genes

  • Highly accuracy

    Deep sequencing and rigorous process

  • Accurate interpretation

    Assessment of variants according to international authoritative database

 

For population


1.Patients with cancer

2.Individuals from a family with hereditary cancer

3.Individuals who cares cancer risk

Immediate consultation or appointment testing services
Please select
  • 受检者
  • 研究人员
  • 医生
  • 公司
  • 其他

You can dial400-158-5999 The hotline contact us, or fill in your contact information and concerns, we will contact you in time